Asymchem Laboratories: difference between revisions
Diff·revision 4 → 5·04:29, 22 Jul 2026
Difference between revision 4 and revision 5 of Asymchem Laboratories. 3 lines changed; the page grew by 696 bytes.
| Revision 4 — 13:17, 21 Jul 2026 EndotoxinEd (talk) close an unbalanced quotation mark 3,977 bytes +795 | Revision 5 — 04:29, 22 Jul 2026 Chromatokid (talk) ce 4,673 bytes +696 | ||
|---|---|---|---|
| 10 | The organisation is one of twenty-eight covered on PeptidePedia under [[Project:Vendor notability]]. Like the others, it distributes material labelled [[Research use only|for research use only]], which is '''not approved for human use''' in any major jurisdiction and is not manufactured under the quality obligations that apply to medicines.{{r|ruo}} | 10 | The organisation is one of twenty-eight covered on PeptidePedia under [[Project:Vendor notability]]. Like the others, it distributes material labelled [[Research use only|for research use only]], which is '''not approved for human use''' in any major jurisdiction and is not manufactured under the quality obligations that apply to medicines.{{r|ruo}} |
| 11 | 11 | ||
| + | 12 | This article describes what is verifiable. Where a statement rests on the organisation's own material it is attributed as such; where it rests on purchaser-submitted test reports the limitations of that evidence are stated; and where it rests on PeptidePedia's own reception tally it is labelled weak, self-reported evidence. Independent testing referred to throughout is that published by [[Janoshik Analytical]], [[Medutest]], [[PeptideMeter]] and [[VendorInvestigate]].{{r|tally}} | |
| + | 13 | ||
| 12 | == Corporate identity and history == | 14 | == Corporate identity and history == |
| 13 | Incorporated in Tianjin in 1998, the organisation holds the earliest incorporation date among the entities covered on this wiki and predates the current research-peptide market by approximately fifteen years.{{r|registry}} A long registry record establishes continuity of a legal entity and nothing else: it does not establish that the entity performed the synthesis, that the analytical claims are sound, or that present practice resembles past practice. Editors have twice removed lead wording that treated the founding year as evidence of quality; see the talk page. | 15 | Incorporated in Tianjin in 1998, the organisation holds the earliest incorporation date among the entities covered on this wiki and predates the current research-peptide market by approximately fifteen years.{{r|registry}} A long registry record establishes continuity of a legal entity and nothing else: it does not establish that the entity performed the synthesis, that the analytical claims are sound, or that present practice resembles past practice. Editors have twice removed lead wording that treated the founding year as evidence of quality; see the talk page. |
| ⋮ | ⋮ | ||
| 23 | <ref name="selfpub">Organisation's own published product and company documentation, retrieved 2026. Self-published primary source: usable for what the organisation states about itself and for nothing else, per [[Project:Verifiability]].</ref> | 25 | <ref name="selfpub">Organisation's own published product and company documentation, retrieved 2026. Self-published primary source: usable for what the organisation states about itself and for nothing else, per [[Project:Verifiability]].</ref> |
| 24 | <ref name="reports">Independent test reports submitted to PeptidePedia by purchasers, 2024–2026. Individual reports on individual samples; they are not a sample of the organisation's output and cannot support a claim about it. See [[Blind sampling]].</ref> | 26 | <ref name="reports">Independent test reports submitted to PeptidePedia by purchasers, 2024–2026. Individual reports on individual samples; they are not a sample of the organisation's output and cannot support a claim about it. See [[Blind sampling]].</ref> |
| + | 27 | <ref name="tally">PeptidePedia reception tally (self-reported submissions; '''weak evidence''' — see [[Project:Sourcing guidelines]]). Self-selected sample; period and count stated at each point of use.</ref> | |
| 25 | <ref name="ruo">Research-use-only labelling practice; see [[Research use only]] for the legal and commercial function of the phrase.</ref> | 28 | <ref name="ruo">Research-use-only labelling practice; see [[Research use only]] for the legal and commercial function of the phrase.</ref> |
| 26 | 29 |